Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Fustier
Augment: Relapsed/Refractory Indolent NHL Patients Were More Sensitive to Next Treatment Following Lenalidomide/Rituximab (R2 ) Than Rituximab/Placebo
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase Ii Study of Durvalumab (Anti-Pd-L1) Combined With Either R-Chop or Lenalidomide and R-Chop in Previously Untreated, High-Risk Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Augment Phase Iii Study: Lenalidomide/Rituximab (R2 ) Improved Efficacy Over Rituximab/Placebo in Relapsed/Refractory Follicular Patients Irrespective of Pod24 Status
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R2 ) VERSUS R PLUS PLACEBO
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Post Hoc Analyses of Patients With Relapsed/Refractory Marginal Zone Lymphoma Who Received Lenalidomide Plus Rituximab (R2 ) vs Rituximab/Placebo (Augment)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
New Developments in the Diagnosis and Treatment of Thyroid Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
No Cost or Safety Advantage to Robot-Assisted Radical Prostatectomy Compared With Open-Procedure Surgery for Patients With Prostate Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Challenges in Ductal Carcinoma in Situ Risk Communication and Decision-Making
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Risk Factors, Pathophysiology, and Treatment of Hot Flashes in Cancer
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Angiogenesis Inhibitors: Current Strategies and Future Prospects
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Population-Based Programs for Increasing Colorectal Cancer Screening in the United States
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cancer Treatment and Survivorship Statistics, 2019
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Germline Mutations in Pancreatic Cancer Become Better Defined
CA - A Cancer Journal for Clinicians
Oncology
Hematology
Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening
CA - A Cancer Journal for Clinicians
Oncology
Hematology
